,30,61 Since FLT3 mutation in AML is known to be associated with PARP1 overexpression,29 here, we separated the FLT3-positive (n = 59) and FLT3 AML-negative (n = 151) subgroups and repeated the analysis. The gene discussed is FLT3; the disease is acute myeloid leukemia.